» Articles » PMID: 37445637

LC-MS/MS-Based Serum Metabolomics and Transcriptome Analyses for the Mechanism of Augmented Renal Clearance

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jul 14
PMID 37445637
Authors
Affiliations
Soon will be listed here.
Abstract

Augmented Renal Clearance (ARC) refers to the increased renal clearance of circulating solute in critically ill patients. In this study, the analytical research method of transcriptomics combined with metabolomics was used to study the pathogenesis of ARC at the transcriptional and metabolic levels. In transcriptomics, 534 samples from 5 datasets in the Gene Expression Omnibus database were analyzed and 834 differential genes associated with ARC were obtained. In metabolomics, we used Ultra-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry to determine the non-targeted metabolites of 102 samples after matching propensity scores, and obtained 45 differential metabolites associated with ARC. The results of the combined analysis showed that purine metabolism, arginine biosynthesis, and arachidonic acid metabolism were changed in patients with ARC. We speculate that the occurrence of ARC may be related to the alteration of renal blood perfusion by LTB4R, ARG1, ALOX5, arginine and prostaglandins E2 through inflammatory response, as well as the effects of , , , , NMDAR, glutamate and cAMP on renal capillary wall permeability.

References
1.
Basu S, Duren W, Evans C, Burant C, Michailidis G, Karnovsky A . Sparse network modeling and metscape-based visualization methods for the analysis of large-scale metabolomics data. Bioinformatics. 2017; 33(10):1545-1553. PMC: 5860222. DOI: 10.1093/bioinformatics/btx012. View

2.
Hefny F, Sambhi S, Morris C, Kung J, Stuart A, Mahmoud S . Drug Dosing in Critically Ill Adult Patients with Augmented Renal Clearance. Eur J Drug Metab Pharmacokinet. 2022; 47(5):607-620. DOI: 10.1007/s13318-022-00779-4. View

3.
Huttner A, von Dach E, Renzoni A, Huttner B, Affaticati M, Pagani L . Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study. Int J Antimicrob Agents. 2015; 45(4):385-92. DOI: 10.1016/j.ijantimicag.2014.12.017. View

4.
Pesonen A, Ben-Hamouda N, Schneider A . Acute kidney injury after brain injury: does it exist?. Minerva Anestesiol. 2020; 87(7):823-827. DOI: 10.23736/S0375-9393.20.14991-5. View

5.
Zhu L, Li F, Zhu D . nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story. Neurosci Bull. 2023; 39(9):1439-1453. PMC: 10113738. DOI: 10.1007/s12264-023-01060-7. View